LATE-BREAKING ABSTRACT: The impact of desensitization therapy prior to lung transplantation

S. Nair, R. Hussain, H. Qureshi, H. Seethamraju, K. Dawson, P. Kolodziejski, A. Parulekar (Houston, United States Of America)

Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Session: Lung transplantation: studies in candidates and recipients
Session type: Poster Discussion
Number: 1477

Congress or journal article abstractE-poster

Abstract

Introduction: Limited data exists on the impact of allosensitization on waitlist time and waitlist mortality in lung transplantation. No published data exists on the impact of desensitzation therapy in lung transplant patients.
Aim: Determine the impact of desensitization therapy on wait time and waitlist mortality.
Methods: We performed a retrospective cohort study based on chart review of all patients listed for lung transplant between 1/1/2007 and 12/31/2010 at The Methodist Hospital. Groups were compared by Chi square test. P-values of 0.05 were considered statistically significant.
Results: Excluding retransplant listings, 299 patients were listed for lung transplant. 30(10%) had panel reactive antibody (PRA) ≥25%, while 269 (90%) had PRA <25%. Median wait time was significantly longer in those with PRA ≥25% (181 days vs. 45 days, p= <0.0001). Waitlist mortality was also significantly higher in those with PRA ≥25% (26.7% vs. 8.6%, p= <0.001). Of the patients with PRA ≥25%, 16 (53.3%) underwent desensitization with intravenous immunoglobulin and plasma exchange +/- rituximab. Of the patients undergoing desensitization therapy, 10 (62.5%) were transplanted, 4 died waiting (25%), and 2 (12.5%) are still waiting. Of the patients with PRA ≥25% that did not receive desensitization therapy, 7 (50%) were transplanted, 4 (28.6%) died waiting, and 3 (21.4%) are still waiting.
Conclusion: PRA ≥25% was associated with a longer wait time and higher waitlist mortality. Desensitization therapy did not improve waitlist time or waitlist mortality when compared to allosensitized patients that did not undergo desensitization. Study is limited by being a retrospective, single center study with low numbers of patients.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Nair, R. Hussain, H. Qureshi, H. Seethamraju, K. Dawson, P. Kolodziejski, A. Parulekar (Houston, United States Of America). LATE-BREAKING ABSTRACT: The impact of desensitization therapy prior to lung transplantation. Eur Respir J 2012; 40: Suppl. 56, 1477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: The effect of route of presentation on lung cancer outcome
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012



LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014

LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


LATE-BREAKING ABSTRACT: On the effectiveness of steroids in acute lung injury: Experimental separation between inflammation and hypoxemia
Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Year: 2012

LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX)
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015


Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001

LATE-BREAKING ABSTRACT: The first successful series of lung transplantations in Russia: a single centre experience
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Current outcome after lung transplantation
Source: Annual Congress 2012 - Lung transplantation in 2012: where are we?
Year: 2012


How to improve long-term outcomes following lung transplantation
Source: International Congress 2019 – Lung transplantation in 2019: where are we?
Year: 2019


LATE-BREAKING ABSTRACT: Amelioration of hyperoxia-induced lung injury in newborn mice using a sphingolipid-based intervention
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012

LATE-BREAKING ABSTRACT: Long-term consequences of central airways stenosis after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Long-term follow-up after lung transplantation – impact of A1-rejection?
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015

The impact of smoking relapse on the outcome after lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

LATE-BREAKING ABSTRACT: The role of eosinophils in Kras-G12D induced lung tumor initiation and progression
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

LATE-BREAKING ABSTRACT: Nitrogen multiple breath washout for diagnosis of biopsy-proven bronchiolitis obliterans in patients after allogeneic stem cell transplantation
Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease
Year: 2016

Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007

Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007